The GPCRact AI model goes beyond AlphaFold3 by predicting whether drugs functionally activate G-protein-coupled receptors ...
Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...
Therapeutic developers are increasingly rebuilding their workflows around AI to bring drugs to patients faster.
Explore the capabilities of a new AI tool that revolutionizes drug discovery by speeding up molecule formation and reducing ...
Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr ...
Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...
A surprising lab discovery reveals a light-powered way to tweak complex drugs faster, cleaner, and later in development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results